Rheumatologists had a Twitter fiesta at the EULAR Congress here in Madrid this week. Here are the top ten tweets
Rheumatologists are having a Twitter fiesta at the EULAR Congress here in Madrid this week. Here are the top ten tweets:
10
Nerd alert in Madrid. 15k(ish) people gathered, all with interest in rheumatology #EULAR2019 pic.twitter.com/grhXrJwG9q
— Cæcilie Skejø (@c_skejoe) June 13, 2019
9
Another night in beautiful Madrid. See you tomorrow #EULAR2019! @RheumNow pic.twitter.com/sJP60m3F6N
— David Liew (@drdavidliew) June 13, 2019
8
Checkpoint inhibitor use is exploding in cancer Rx. Big data review of 13000 cases of immune mediated reactions are mostly endo, GI and pulmonary and NOT rheumatic THUS0628 #EULAR2019 @RheumNow pic.twitter.com/iYO8t6ALBx
— Janet Pope (@Janetbirdope) June 13, 2019
7
Holy moly! Goh et al. (2007) Human Disease network is so cool!! RN: in the big data session-Harald Schmidt discusses treatments based on disease networks. A very different approach here- thinking of disease definitions as networks. #EULAR2019 pic.twitter.com/TKmeYRW9Uh
— Kayla Amodeo,PhD (@doc_amodeo) June 13, 2019
6
Interesting discussion about nocebo effect when swapping to biosimilars. “Cheaper” may trigger this.
Health professionals need to understand we are salespeople in many situations. Language, trust, style matter. #EULAR2019 pic.twitter.com/29GP6cmXhQ
— Dr Irwin Lim (@_connectedcare) June 13, 2019
5
ANCA #VASCULITIS
??A maintenance treatment should be prescribed
??Anti-PR3 patients > MPO
??Rituximab is the best drug to maintain remission
??Some patients could deserve a”very long term maintenance treatment”,may be all life
??A specific approach is needed in EGPA#EULAR2019 pic.twitter.com/s3JlUahN4m— Juan Ovalles, MD, PhD (@DrJuanOvalles) June 12, 2019
4
No point on repeating ANA testing PPV 0.01 according to this abstract by Yeo et al. #EULAR2019 #Rheumatology @RheumNow pic.twitter.com/kX0angBvqd
— Sebastian Rodriguez-García (@sdlcrodriguez) June 12, 2019
3
Great overview on current status on disease modification in OA by Hochberg But not a single mention of the word biomechanics??? I know EULAR is a rheumatology conf, but the disease is far from just driven by inflammation… ???#EULAR2019 @OARSInews pic.twitter.com/JWd3Ihj4S7
— Martin Englund (@dr_englund) June 12, 2019
2
Updated treatment algorithm for various pathological subtypes of #Lupus Nephritis #EULAR2019 pic.twitter.com/Uun2OQXJLl
— Juan Ovalles, MD, PhD (@DrJuanOvalles) June 13, 2019
1
Osteoporosis Medication. When to stop? When to switch?
I find this hard so here are Swiss guidelines #eular2019 pic.twitter.com/WNhDanIXRg
— Dr Irwin Lim (@_connectedcare) June 12, 2019
